Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

October 01, 2020; Volume 98,Issue 4
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Abboud, Khalil A.

    1. You have access
      Differing Activity Profiles of the Stereoisomers of 2,3,5,6TMP-TQS, a Putative Silent Allosteric Modulator of α7 nAChR
      Roger L. Papke, Sumanta Garai, Clare Stokes, Nicole A. Horenstein, Arthur D. Zimmerman, Khalil A. Abboud and Ganesh A. Thakur
      Molecular Pharmacology October 2020, 98 (4) 292-302; DOI: https://doi.org/10.1124/mol.120.119958
  2. Abd-Elrahman, Khaled S.

    1. You have access
      Targeting Vesicular Glutamate Transporter Machinery: Implications on Metabotropic Glutamate Receptor 5 Signaling and Behavior
      Karim S. Ibrahim, Khaled S. Abd-Elrahman, Salah El Mestikawy and Stephen S.G. Ferguson
      Molecular Pharmacology October 2020, 98 (4) 315-328; DOI: https://doi.org/10.1124/mol.120.000089
    2. You have access
      Targeting Vesicular Glutamate Transporter Machinery: Implications on Metabotropic Glutamate Receptor 5 Signaling and Behavior
      Karim S. Ibrahim, Khaled S. Abd-Elrahman, Salah El Mestikawy and Stephen S.G. Ferguson
      Molecular Pharmacology October 2020, 98 (4) 314-327; DOI: https://doi.org/10.1124/molpharm.120.000089
  3. Abderrahman, Balkees

    1. Open Access
      Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast Cancer
      Balkees Abderrahman, Philipp Y. Maximov, Ramona F. Curpan, Jay S. Hanspal, Ping Fan, Rui Xiong, Debra A. Tonetti, Gregory R.J. Thatcher and V. Craig Jordan
      Molecular Pharmacology October 2020, 98 (4) 363-380; DOI: https://doi.org/10.1124/molpharm.120.000054
    2. Open Access
      Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast Cancer
      Balkees Abderrahman, Philipp Y. Maximov, Ramona F. Curpan, Jay S. Hanspal, Ping Fan, Rui Xiong, Debra A. Tonetti, Gregory R.J. Thatcher and V. Craig Jordan
      Molecular Pharmacology October 2020, 98 (4) 364-381; DOI: https://doi.org/10.1124/molpharm.120.000054
  4. Akk, Gustav

    1. You have access
      Analysis of Modulation of the ρ1 GABAA Receptor by Combinations of Inhibitory and Potentiating Neurosteroids Reveals Shared and Distinct Binding Sites
      Allison L. Germann, David E. Reichert, Ariel B. Burbridge, Spencer R. Pierce, Alex S. Evers, Joe Henry Steinbach and Gustav Akk
      Molecular Pharmacology October 2020, 98 (4) 280-291; DOI: https://doi.org/10.1124/mol.120.119842
    2. You have access
      Enhancement of Muscimol Binding and Gating by Allosteric Modulators of the GABAA Receptor: Relating Occupancy to State Functions
      Gustav Akk, Allison L. Germann, Yusuke Sugasawa, Spencer R. Pierce, Alex S. Evers and Joe Henry Steinbach
      Molecular Pharmacology October 2020, 98 (4) 303-313; DOI: https://doi.org/10.1124/molpharm.120.000066
  5. Al-Hasani, Ream

    1. You have access
      Pain, Motivation, Migraine, and the Microbiome: New Frontiers for Opioid Systems and Disease
      Kyle E. Parker, Elizabeth Sugiarto, Anna M.W. Taylor, Amynah A. Pradhan and Ream Al-Hasani
      Molecular Pharmacology October 2020, 98 (4) 433-444; DOI: https://doi.org/10.1124/mol.120.119438
  6. Aleman, Monica

    1. You have access
      Dietary Caffeine Synergizes Adverse Peripheral and Central Responses to Anesthesia in Malignant Hyperthermia Susceptible Mice
      Monica Aleman, Rui Zhang, Wei Feng, Lihong Qi, Jose R. Lopez, Chelsea Crowe, Yao Dong, Genady Cherednichenko and Isaac N. Pessah
      Molecular Pharmacology October 2020, 98 (4) 351-363; DOI: https://doi.org/10.1124/mol.120.119412
  7. Arttamangkul, Seksiri

    1. You have access
      Chronic Treatment with Morphine Disrupts Acute Kinase-Dependent Desensitization of GPCRs
      Emily R. Leff, Seksiri Arttamangkul and John T. Williams
      Molecular Pharmacology October 2020, 98 (4) 497-507; DOI: https://doi.org/10.1124/mol.119.119362

B

  1. Bagley, E.E.

    1. You have access
      Neprilysin Controls the Synaptic Activity of Neuropeptides in the Intercalated Cells of the Amygdala
      G.C. Gregoriou, S.D. Patel, B.L. Winters and E.E. Bagley
      Molecular Pharmacology October 2020, 98 (4) 454-461; DOI: https://doi.org/10.1124/mol.119.119370
  2. Barker, K.E.

    1. You have access
      Spinal Opioid Tolerance Depends upon Platelet-Derived Growth Factor Receptor-β Signaling, Not μ-Opioid Receptor Internalization
      S. Puig, K.E. Barker, S.R. Szott, P.T. Kann, J.S. Morris and H.B. Gutstein
      Molecular Pharmacology October 2020, 98 (4) 487-496; DOI: https://doi.org/10.1124/mol.120.119552
  3. Barnett, Miriam E.

    1. You have access
      Unique Pharmacological Properties of the Kappa Opioid Receptor Signaling Through Gαz as Shown with Bioluminescence Resonance Energy Transfer
      Miriam E. Barnett, Brian I. Knapp and Jean M. Bidlack
      Molecular Pharmacology October 2020, 98 (4) 462-474; DOI: https://doi.org/10.1124/mol.120.119404
  4. Bidlack, Jean M.

    1. You have access
      Unique Pharmacological Properties of the Kappa Opioid Receptor Signaling Through Gαz as Shown with Bioluminescence Resonance Energy Transfer
      Miriam E. Barnett, Brian I. Knapp and Jean M. Bidlack
      Molecular Pharmacology October 2020, 98 (4) 462-474; DOI: https://doi.org/10.1124/mol.120.119404
  5. Birdsong, William T.

    1. Open Access
      Recent Progress in Opioid Research from an Electrophysiological Perspective
      William T. Birdsong and John T. Williams
      Molecular Pharmacology October 2020, 98 (4) 401-409; DOI: https://doi.org/10.1124/mol.119.119040
  6. Blendy, J.A.

    1. Open Access
      Bidirectional Relationship between Opioids and Disrupted Sleep: Putative Mechanisms
      D. Eacret, S.C. Veasey and J.A. Blendy
      Molecular Pharmacology October 2020, 98 (4) 445-453; DOI: https://doi.org/10.1124/mol.119.119107
  7. Burbridge, Ariel B.

    1. You have access
      Analysis of Modulation of the ρ1 GABAA Receptor by Combinations of Inhibitory and Potentiating Neurosteroids Reveals Shared and Distinct Binding Sites
      Allison L. Germann, David E. Reichert, Ariel B. Burbridge, Spencer R. Pierce, Alex S. Evers, Joe Henry Steinbach and Gustav Akk
      Molecular Pharmacology October 2020, 98 (4) 280-291; DOI: https://doi.org/10.1124/mol.120.119842
  8. Burris, Thomas P.

    1. You have access
      Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize Drugs
      Zdenek Dvorak, Max Klapholz, Thomas P. Burris, Benjamin P. Willing, Antimo Gioiello, Roberto Pellicciari, Francesco Galli, John March, Stephen J. O’Keefe, R. Balfour Sartor, Chang H. Kim, Maayan Levy and Sridhar Mani
      Molecular Pharmacology October 2020, 98 (4) 328-334; DOI: https://doi.org/10.1124/molpharm.120.000035
    2. You have access
      Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize Drugs
      Zdenek Dvorak, Max Klapholz, Thomas P. Burris, Benjamin P. Willing, Antimo Gioiello, Roberto Pellicciari, Francesco Galli, John March, Stephen J. O’Keefe, R. Balfour Sartor, Chang H. Kim, Maayan Levy and Sridhar Mani
      Molecular Pharmacology October 2020, 98 (4) 343-349; DOI: https://doi.org/10.1124/molpharm.120.000035

C

  1. Canals, Meritxell

    1. You have access
      Opioid Pharmacology under the Microscope
      Damien Jullié, Arisbel B. Gondin, Mark von Zastrow and Meritxell Canals
      Molecular Pharmacology October 2020, 98 (4) 425-432; DOI: https://doi.org/10.1124/mol.119.119321
  2. Carroll, F. Ivy

    1. You have access
      Nicotinic Acetylcholine Receptor Accessory Subunits Determine the Activity Profile of Epibatidine Derivatives
      Lu Wenchi Corrie, Clare Stokes, Jenny L. Wilkerson, F. Ivy Carroll, Lance R. McMahon and Roger L. Papke
      Molecular Pharmacology October 2020, 98 (4) 328-342; DOI: https://doi.org/10.1124/molpharm.120.000037
    2. You have access
      Nicotinic Acetylcholine Receptor Accessory Subunits Determine the Activity Profile of Epibatidine Derivatives
      Lu Wenchi Corrie, Clare Stokes, Jenny L. Wilkerson, F. Ivy Carroll, Lance R. McMahon and Roger L. Papke
      Molecular Pharmacology October 2020, 98 (4) 335-349; DOI: https://doi.org/10.1124/molpharm.120.000037
  3. Cherednichenko, Genady

    1. You have access
      Dietary Caffeine Synergizes Adverse Peripheral and Central Responses to Anesthesia in Malignant Hyperthermia Susceptible Mice
      Monica Aleman, Rui Zhang, Wei Feng, Lihong Qi, Jose R. Lopez, Chelsea Crowe, Yao Dong, Genady Cherednichenko and Isaac N. Pessah
      Molecular Pharmacology October 2020, 98 (4) 351-363; DOI: https://doi.org/10.1124/mol.120.119412
  4. Christie, Macdonald J.

    1. You have access
      Intrinsic Efficacy of Opioid Ligands and Its Importance for Apparent Bias, Operational Analysis, and Therapeutic Window
      Alexander Gillis, Varun Sreenivasan and Macdonald J. Christie
      Molecular Pharmacology October 2020, 98 (4) 410-424; DOI: https://doi.org/10.1124/mol.119.119214
  5. Corrie, Lu Wenchi

    1. You have access
      Nicotinic Acetylcholine Receptor Accessory Subunits Determine the Activity Profile of Epibatidine Derivatives
      Lu Wenchi Corrie, Clare Stokes, Jenny L. Wilkerson, F. Ivy Carroll, Lance R. McMahon and Roger L. Papke
      Molecular Pharmacology October 2020, 98 (4) 328-342; DOI: https://doi.org/10.1124/molpharm.120.000037
    2. You have access
      Nicotinic Acetylcholine Receptor Accessory Subunits Determine the Activity Profile of Epibatidine Derivatives
      Lu Wenchi Corrie, Clare Stokes, Jenny L. Wilkerson, F. Ivy Carroll, Lance R. McMahon and Roger L. Papke
      Molecular Pharmacology October 2020, 98 (4) 335-349; DOI: https://doi.org/10.1124/molpharm.120.000037
  6. Cox, Brian M.

    1. You have access
      A Concise Review of Concepts in Opioid Pharmacology up to the Discovery of Endogenous Opioids
      Brian M. Cox
      Molecular Pharmacology October 2020, 98 (4) 392-400; DOI: https://doi.org/10.1124/mol.120.119420
  7. Crowe, Chelsea

    1. You have access
      Dietary Caffeine Synergizes Adverse Peripheral and Central Responses to Anesthesia in Malignant Hyperthermia Susceptible Mice
      Monica Aleman, Rui Zhang, Wei Feng, Lihong Qi, Jose R. Lopez, Chelsea Crowe, Yao Dong, Genady Cherednichenko and Isaac N. Pessah
      Molecular Pharmacology October 2020, 98 (4) 351-363; DOI: https://doi.org/10.1124/mol.120.119412
  8. Curpan, Ramona F.

    1. Open Access
      Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast Cancer
      Balkees Abderrahman, Philipp Y. Maximov, Ramona F. Curpan, Jay S. Hanspal, Ping Fan, Rui Xiong, Debra A. Tonetti, Gregory R.J. Thatcher and V. Craig Jordan
      Molecular Pharmacology October 2020, 98 (4) 363-380; DOI: https://doi.org/10.1124/molpharm.120.000054
    2. Open Access
      Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast Cancer
      Balkees Abderrahman, Philipp Y. Maximov, Ramona F. Curpan, Jay S. Hanspal, Ping Fan, Rui Xiong, Debra A. Tonetti, Gregory R.J. Thatcher and V. Craig Jordan
      Molecular Pharmacology October 2020, 98 (4) 364-381; DOI: https://doi.org/10.1124/molpharm.120.000054

D

  1. Dong, Yao

    1. You have access
      Dietary Caffeine Synergizes Adverse Peripheral and Central Responses to Anesthesia in Malignant Hyperthermia Susceptible Mice
      Monica Aleman, Rui Zhang, Wei Feng, Lihong Qi, Jose R. Lopez, Chelsea Crowe, Yao Dong, Genady Cherednichenko and Isaac N. Pessah
      Molecular Pharmacology October 2020, 98 (4) 351-363; DOI: https://doi.org/10.1124/mol.120.119412
  2. Dvorak, Zdenek

    1. You have access
      Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize Drugs
      Zdenek Dvorak, Max Klapholz, Thomas P. Burris, Benjamin P. Willing, Antimo Gioiello, Roberto Pellicciari, Francesco Galli, John March, Stephen J. O’Keefe, R. Balfour Sartor, Chang H. Kim, Maayan Levy and Sridhar Mani
      Molecular Pharmacology October 2020, 98 (4) 328-334; DOI: https://doi.org/10.1124/molpharm.120.000035
    2. You have access
      Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize Drugs
      Zdenek Dvorak, Max Klapholz, Thomas P. Burris, Benjamin P. Willing, Antimo Gioiello, Roberto Pellicciari, Francesco Galli, John March, Stephen J. O’Keefe, R. Balfour Sartor, Chang H. Kim, Maayan Levy and Sridhar Mani
      Molecular Pharmacology October 2020, 98 (4) 343-349; DOI: https://doi.org/10.1124/molpharm.120.000035

E

  1. Eacret, D.

    1. Open Access
      Bidirectional Relationship between Opioids and Disrupted Sleep: Putative Mechanisms
      D. Eacret, S.C. Veasey and J.A. Blendy
      Molecular Pharmacology October 2020, 98 (4) 445-453; DOI: https://doi.org/10.1124/mol.119.119107
  2. El Mestikawy, Salah

    1. You have access
      Targeting Vesicular Glutamate Transporter Machinery: Implications on Metabotropic Glutamate Receptor 5 Signaling and Behavior
      Karim S. Ibrahim, Khaled S. Abd-Elrahman, Salah El Mestikawy and Stephen S.G. Ferguson
      Molecular Pharmacology October 2020, 98 (4) 315-328; DOI: https://doi.org/10.1124/mol.120.000089
    2. You have access
      Targeting Vesicular Glutamate Transporter Machinery: Implications on Metabotropic Glutamate Receptor 5 Signaling and Behavior
      Karim S. Ibrahim, Khaled S. Abd-Elrahman, Salah El Mestikawy and Stephen S.G. Ferguson
      Molecular Pharmacology October 2020, 98 (4) 314-327; DOI: https://doi.org/10.1124/molpharm.120.000089
  3. Evers, Alex S.

    1. You have access
      Analysis of Modulation of the ρ1 GABAA Receptor by Combinations of Inhibitory and Potentiating Neurosteroids Reveals Shared and Distinct Binding Sites
      Allison L. Germann, David E. Reichert, Ariel B. Burbridge, Spencer R. Pierce, Alex S. Evers, Joe Henry Steinbach and Gustav Akk
      Molecular Pharmacology October 2020, 98 (4) 280-291; DOI: https://doi.org/10.1124/mol.120.119842
    2. You have access
      Enhancement of Muscimol Binding and Gating by Allosteric Modulators of the GABAA Receptor: Relating Occupancy to State Functions
      Gustav Akk, Allison L. Germann, Yusuke Sugasawa, Spencer R. Pierce, Alex S. Evers and Joe Henry Steinbach
      Molecular Pharmacology October 2020, 98 (4) 303-313; DOI: https://doi.org/10.1124/molpharm.120.000066

F

  1. Fan, Ping

    1. Open Access
      Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast Cancer
      Balkees Abderrahman, Philipp Y. Maximov, Ramona F. Curpan, Jay S. Hanspal, Ping Fan, Rui Xiong, Debra A. Tonetti, Gregory R.J. Thatcher and V. Craig Jordan
      Molecular Pharmacology October 2020, 98 (4) 363-380; DOI: https://doi.org/10.1124/molpharm.120.000054
    2. Open Access
      Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast Cancer
      Balkees Abderrahman, Philipp Y. Maximov, Ramona F. Curpan, Jay S. Hanspal, Ping Fan, Rui Xiong, Debra A. Tonetti, Gregory R.J. Thatcher and V. Craig Jordan
      Molecular Pharmacology October 2020, 98 (4) 364-381; DOI: https://doi.org/10.1124/molpharm.120.000054
  2. Feng, Wei

    1. You have access
      Dietary Caffeine Synergizes Adverse Peripheral and Central Responses to Anesthesia in Malignant Hyperthermia Susceptible Mice
      Monica Aleman, Rui Zhang, Wei Feng, Lihong Qi, Jose R. Lopez, Chelsea Crowe, Yao Dong, Genady Cherednichenko and Isaac N. Pessah
      Molecular Pharmacology October 2020, 98 (4) 351-363; DOI: https://doi.org/10.1124/mol.120.119412
  3. Ferguson, Stephen S.G.

    1. You have access
      Targeting Vesicular Glutamate Transporter Machinery: Implications on Metabotropic Glutamate Receptor 5 Signaling and Behavior
      Karim S. Ibrahim, Khaled S. Abd-Elrahman, Salah El Mestikawy and Stephen S.G. Ferguson
      Molecular Pharmacology October 2020, 98 (4) 315-328; DOI: https://doi.org/10.1124/mol.120.000089
    2. You have access
      Targeting Vesicular Glutamate Transporter Machinery: Implications on Metabotropic Glutamate Receptor 5 Signaling and Behavior
      Karim S. Ibrahim, Khaled S. Abd-Elrahman, Salah El Mestikawy and Stephen S.G. Ferguson
      Molecular Pharmacology October 2020, 98 (4) 314-327; DOI: https://doi.org/10.1124/molpharm.120.000089
  4. Filizola, Marta

    1. Open Access
      Atomic-Level Characterization of the Methadone-Stabilized Active Conformation of µ-Opioid Receptor
      Abhijeet Kapoor, Davide Provasi and Marta Filizola
      Molecular Pharmacology October 2020, 98 (4) 475-486; DOI: https://doi.org/10.1124/mol.119.119339

G

  1. Galli, Francesco

    1. You have access
      Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize Drugs
      Zdenek Dvorak, Max Klapholz, Thomas P. Burris, Benjamin P. Willing, Antimo Gioiello, Roberto Pellicciari, Francesco Galli, John March, Stephen J. O’Keefe, R. Balfour Sartor, Chang H. Kim, Maayan Levy and Sridhar Mani
      Molecular Pharmacology October 2020, 98 (4) 328-334; DOI: https://doi.org/10.1124/molpharm.120.000035
    2. You have access
      Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize Drugs
      Zdenek Dvorak, Max Klapholz, Thomas P. Burris, Benjamin P. Willing, Antimo Gioiello, Roberto Pellicciari, Francesco Galli, John March, Stephen J. O’Keefe, R. Balfour Sartor, Chang H. Kim, Maayan Levy and Sridhar Mani
      Molecular Pharmacology October 2020, 98 (4) 343-349; DOI: https://doi.org/10.1124/molpharm.120.000035
  2. Garai, Sumanta

    1. You have access
      Differing Activity Profiles of the Stereoisomers of 2,3,5,6TMP-TQS, a Putative Silent Allosteric Modulator of α7 nAChR
      Roger L. Papke, Sumanta Garai, Clare Stokes, Nicole A. Horenstein, Arthur D. Zimmerman, Khalil A. Abboud and Ganesh A. Thakur
      Molecular Pharmacology October 2020, 98 (4) 292-302; DOI: https://doi.org/10.1124/mol.120.119958
  3. Germann, Allison L.

    1. You have access
      Analysis of Modulation of the ρ1 GABAA Receptor by Combinations of Inhibitory and Potentiating Neurosteroids Reveals Shared and Distinct Binding Sites
      Allison L. Germann, David E. Reichert, Ariel B. Burbridge, Spencer R. Pierce, Alex S. Evers, Joe Henry Steinbach and Gustav Akk
      Molecular Pharmacology October 2020, 98 (4) 280-291; DOI: https://doi.org/10.1124/mol.120.119842
    2. You have access
      Enhancement of Muscimol Binding and Gating by Allosteric Modulators of the GABAA Receptor: Relating Occupancy to State Functions
      Gustav Akk, Allison L. Germann, Yusuke Sugasawa, Spencer R. Pierce, Alex S. Evers and Joe Henry Steinbach
      Molecular Pharmacology October 2020, 98 (4) 303-313; DOI: https://doi.org/10.1124/molpharm.120.000066
  4. Gewirtz, David A.

    1. You have access
      “Emerging Concepts”: New Article Category in Molecular Pharmacology
      David A. Gewirtz
      Molecular Pharmacology October 2020, 98 (4) 350; DOI: https://doi.org/10.1124/molpharm.120.000133
  5. Gillis, Alexander

    1. You have access
      Intrinsic Efficacy of Opioid Ligands and Its Importance for Apparent Bias, Operational Analysis, and Therapeutic Window
      Alexander Gillis, Varun Sreenivasan and Macdonald J. Christie
      Molecular Pharmacology October 2020, 98 (4) 410-424; DOI: https://doi.org/10.1124/mol.119.119214
  6. Gioiello, Antimo

    1. You have access
      Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize Drugs
      Zdenek Dvorak, Max Klapholz, Thomas P. Burris, Benjamin P. Willing, Antimo Gioiello, Roberto Pellicciari, Francesco Galli, John March, Stephen J. O’Keefe, R. Balfour Sartor, Chang H. Kim, Maayan Levy and Sridhar Mani
      Molecular Pharmacology October 2020, 98 (4) 328-334; DOI: https://doi.org/10.1124/molpharm.120.000035
    2. You have access
      Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize Drugs
      Zdenek Dvorak, Max Klapholz, Thomas P. Burris, Benjamin P. Willing, Antimo Gioiello, Roberto Pellicciari, Francesco Galli, John March, Stephen J. O’Keefe, R. Balfour Sartor, Chang H. Kim, Maayan Levy and Sridhar Mani
      Molecular Pharmacology October 2020, 98 (4) 343-349; DOI: https://doi.org/10.1124/molpharm.120.000035
  7. Gondin, Arisbel B.

    1. You have access
      Opioid Pharmacology under the Microscope
      Damien Jullié, Arisbel B. Gondin, Mark von Zastrow and Meritxell Canals
      Molecular Pharmacology October 2020, 98 (4) 425-432; DOI: https://doi.org/10.1124/mol.119.119321
  8. Gregoriou, G.C.

    1. You have access
      Neprilysin Controls the Synaptic Activity of Neuropeptides in the Intercalated Cells of the Amygdala
      G.C. Gregoriou, S.D. Patel, B.L. Winters and E.E. Bagley
      Molecular Pharmacology October 2020, 98 (4) 454-461; DOI: https://doi.org/10.1124/mol.119.119370
  9. Gutstein, H.B.

    1. You have access
      Spinal Opioid Tolerance Depends upon Platelet-Derived Growth Factor Receptor-β Signaling, Not μ-Opioid Receptor Internalization
      S. Puig, K.E. Barker, S.R. Szott, P.T. Kann, J.S. Morris and H.B. Gutstein
      Molecular Pharmacology October 2020, 98 (4) 487-496; DOI: https://doi.org/10.1124/mol.120.119552

H

  1. Hanspal, Jay S.

    1. Open Access
      Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast Cancer
      Balkees Abderrahman, Philipp Y. Maximov, Ramona F. Curpan, Jay S. Hanspal, Ping Fan, Rui Xiong, Debra A. Tonetti, Gregory R.J. Thatcher and V. Craig Jordan
      Molecular Pharmacology October 2020, 98 (4) 363-380; DOI: https://doi.org/10.1124/molpharm.120.000054
    2. Open Access
      Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast Cancer
      Balkees Abderrahman, Philipp Y. Maximov, Ramona F. Curpan, Jay S. Hanspal, Ping Fan, Rui Xiong, Debra A. Tonetti, Gregory R.J. Thatcher and V. Craig Jordan
      Molecular Pharmacology October 2020, 98 (4) 364-381; DOI: https://doi.org/10.1124/molpharm.120.000054
  2. Horenstein, Nicole A.

    1. You have access
      Differing Activity Profiles of the Stereoisomers of 2,3,5,6TMP-TQS, a Putative Silent Allosteric Modulator of α7 nAChR
      Roger L. Papke, Sumanta Garai, Clare Stokes, Nicole A. Horenstein, Arthur D. Zimmerman, Khalil A. Abboud and Ganesh A. Thakur
      Molecular Pharmacology October 2020, 98 (4) 292-302; DOI: https://doi.org/10.1124/mol.120.119958

I

  1. Ibrahim, Karim S.

    1. You have access
      Targeting Vesicular Glutamate Transporter Machinery: Implications on Metabotropic Glutamate Receptor 5 Signaling and Behavior
      Karim S. Ibrahim, Khaled S. Abd-Elrahman, Salah El Mestikawy and Stephen S.G. Ferguson
      Molecular Pharmacology October 2020, 98 (4) 315-328; DOI: https://doi.org/10.1124/mol.120.000089
    2. You have access
      Targeting Vesicular Glutamate Transporter Machinery: Implications on Metabotropic Glutamate Receptor 5 Signaling and Behavior
      Karim S. Ibrahim, Khaled S. Abd-Elrahman, Salah El Mestikawy and Stephen S.G. Ferguson
      Molecular Pharmacology October 2020, 98 (4) 314-327; DOI: https://doi.org/10.1124/molpharm.120.000089

J

  1. Jordan, V. Craig

    1. Open Access
      Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast Cancer
      Balkees Abderrahman, Philipp Y. Maximov, Ramona F. Curpan, Jay S. Hanspal, Ping Fan, Rui Xiong, Debra A. Tonetti, Gregory R.J. Thatcher and V. Craig Jordan
      Molecular Pharmacology October 2020, 98 (4) 363-380; DOI: https://doi.org/10.1124/molpharm.120.000054
    2. Open Access
      Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast Cancer
      Balkees Abderrahman, Philipp Y. Maximov, Ramona F. Curpan, Jay S. Hanspal, Ping Fan, Rui Xiong, Debra A. Tonetti, Gregory R.J. Thatcher and V. Craig Jordan
      Molecular Pharmacology October 2020, 98 (4) 364-381; DOI: https://doi.org/10.1124/molpharm.120.000054
  2. Jullié, Damien

    1. You have access
      Opioid Pharmacology under the Microscope
      Damien Jullié, Arisbel B. Gondin, Mark von Zastrow and Meritxell Canals
      Molecular Pharmacology October 2020, 98 (4) 425-432; DOI: https://doi.org/10.1124/mol.119.119321

K

  1. Kabbani, N.

    1. You have access
      Response to Comments on “Does COVID19 Infect the Brain? If So, Smokers Might Be at a Higher Risk”
      N. Kabbani and J.L. Olds
      Molecular Pharmacology October 2020, 98 (4) 384-385; DOI: https://doi.org/10.1124/molpharm.120.000120
  2. Kann, P.T.

    1. You have access
      Spinal Opioid Tolerance Depends upon Platelet-Derived Growth Factor Receptor-β Signaling, Not μ-Opioid Receptor Internalization
      S. Puig, K.E. Barker, S.R. Szott, P.T. Kann, J.S. Morris and H.B. Gutstein
      Molecular Pharmacology October 2020, 98 (4) 487-496; DOI: https://doi.org/10.1124/mol.120.119552
  3. Kapoor, Abhijeet

    1. Open Access
      Atomic-Level Characterization of the Methadone-Stabilized Active Conformation of µ-Opioid Receptor
      Abhijeet Kapoor, Davide Provasi and Marta Filizola
      Molecular Pharmacology October 2020, 98 (4) 475-486; DOI: https://doi.org/10.1124/mol.119.119339
  4. Kim, Chang H.

    1. You have access
      Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize Drugs
      Zdenek Dvorak, Max Klapholz, Thomas P. Burris, Benjamin P. Willing, Antimo Gioiello, Roberto Pellicciari, Francesco Galli, John March, Stephen J. O’Keefe, R. Balfour Sartor, Chang H. Kim, Maayan Levy and Sridhar Mani
      Molecular Pharmacology October 2020, 98 (4) 328-334; DOI: https://doi.org/10.1124/molpharm.120.000035
    2. You have access
      Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize Drugs
      Zdenek Dvorak, Max Klapholz, Thomas P. Burris, Benjamin P. Willing, Antimo Gioiello, Roberto Pellicciari, Francesco Galli, John March, Stephen J. O’Keefe, R. Balfour Sartor, Chang H. Kim, Maayan Levy and Sridhar Mani
      Molecular Pharmacology October 2020, 98 (4) 343-349; DOI: https://doi.org/10.1124/molpharm.120.000035
  5. Klapholz, Max

    1. You have access
      Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize Drugs
      Zdenek Dvorak, Max Klapholz, Thomas P. Burris, Benjamin P. Willing, Antimo Gioiello, Roberto Pellicciari, Francesco Galli, John March, Stephen J. O’Keefe, R. Balfour Sartor, Chang H. Kim, Maayan Levy and Sridhar Mani
      Molecular Pharmacology October 2020, 98 (4) 328-334; DOI: https://doi.org/10.1124/molpharm.120.000035
    2. You have access
      Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize Drugs
      Zdenek Dvorak, Max Klapholz, Thomas P. Burris, Benjamin P. Willing, Antimo Gioiello, Roberto Pellicciari, Francesco Galli, John March, Stephen J. O’Keefe, R. Balfour Sartor, Chang H. Kim, Maayan Levy and Sridhar Mani
      Molecular Pharmacology October 2020, 98 (4) 343-349; DOI: https://doi.org/10.1124/molpharm.120.000035
  6. Knapp, Brian I.

    1. You have access
      Unique Pharmacological Properties of the Kappa Opioid Receptor Signaling Through Gαz as Shown with Bioluminescence Resonance Energy Transfer
      Miriam E. Barnett, Brian I. Knapp and Jean M. Bidlack
      Molecular Pharmacology October 2020, 98 (4) 462-474; DOI: https://doi.org/10.1124/mol.120.119404

L

  1. Leff, Emily R.

    1. You have access
      Chronic Treatment with Morphine Disrupts Acute Kinase-Dependent Desensitization of GPCRs
      Emily R. Leff, Seksiri Arttamangkul and John T. Williams
      Molecular Pharmacology October 2020, 98 (4) 497-507; DOI: https://doi.org/10.1124/mol.119.119362
  2. Levy, Maayan

    1. You have access
      Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize Drugs
      Zdenek Dvorak, Max Klapholz, Thomas P. Burris, Benjamin P. Willing, Antimo Gioiello, Roberto Pellicciari, Francesco Galli, John March, Stephen J. O’Keefe, R. Balfour Sartor, Chang H. Kim, Maayan Levy and Sridhar Mani
      Molecular Pharmacology October 2020, 98 (4) 328-334; DOI: https://doi.org/10.1124/molpharm.120.000035
    2. You have access
      Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize Drugs
      Zdenek Dvorak, Max Klapholz, Thomas P. Burris, Benjamin P. Willing, Antimo Gioiello, Roberto Pellicciari, Francesco Galli, John March, Stephen J. O’Keefe, R. Balfour Sartor, Chang H. Kim, Maayan Levy and Sridhar Mani
      Molecular Pharmacology October 2020, 98 (4) 343-349; DOI: https://doi.org/10.1124/molpharm.120.000035
  3. Lopez, Jose R.

    1. You have access
      Dietary Caffeine Synergizes Adverse Peripheral and Central Responses to Anesthesia in Malignant Hyperthermia Susceptible Mice
      Monica Aleman, Rui Zhang, Wei Feng, Lihong Qi, Jose R. Lopez, Chelsea Crowe, Yao Dong, Genady Cherednichenko and Isaac N. Pessah
      Molecular Pharmacology October 2020, 98 (4) 351-363; DOI: https://doi.org/10.1124/mol.120.119412

M

  1. Mani, Sridhar

    1. You have access
      Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize Drugs
      Zdenek Dvorak, Max Klapholz, Thomas P. Burris, Benjamin P. Willing, Antimo Gioiello, Roberto Pellicciari, Francesco Galli, John March, Stephen J. O’Keefe, R. Balfour Sartor, Chang H. Kim, Maayan Levy and Sridhar Mani
      Molecular Pharmacology October 2020, 98 (4) 328-334; DOI: https://doi.org/10.1124/molpharm.120.000035
    2. You have access
      Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize Drugs
      Zdenek Dvorak, Max Klapholz, Thomas P. Burris, Benjamin P. Willing, Antimo Gioiello, Roberto Pellicciari, Francesco Galli, John March, Stephen J. O’Keefe, R. Balfour Sartor, Chang H. Kim, Maayan Levy and Sridhar Mani
      Molecular Pharmacology October 2020, 98 (4) 343-349; DOI: https://doi.org/10.1124/molpharm.120.000035
  2. March, John

    1. You have access
      Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize Drugs
      Zdenek Dvorak, Max Klapholz, Thomas P. Burris, Benjamin P. Willing, Antimo Gioiello, Roberto Pellicciari, Francesco Galli, John March, Stephen J. O’Keefe, R. Balfour Sartor, Chang H. Kim, Maayan Levy and Sridhar Mani
      Molecular Pharmacology October 2020, 98 (4) 328-334; DOI: https://doi.org/10.1124/molpharm.120.000035
    2. You have access
      Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize Drugs
      Zdenek Dvorak, Max Klapholz, Thomas P. Burris, Benjamin P. Willing, Antimo Gioiello, Roberto Pellicciari, Francesco Galli, John March, Stephen J. O’Keefe, R. Balfour Sartor, Chang H. Kim, Maayan Levy and Sridhar Mani
      Molecular Pharmacology October 2020, 98 (4) 343-349; DOI: https://doi.org/10.1124/molpharm.120.000035
  3. Maximov, Philipp Y.

    1. Open Access
      Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast Cancer
      Balkees Abderrahman, Philipp Y. Maximov, Ramona F. Curpan, Jay S. Hanspal, Ping Fan, Rui Xiong, Debra A. Tonetti, Gregory R.J. Thatcher and V. Craig Jordan
      Molecular Pharmacology October 2020, 98 (4) 363-380; DOI: https://doi.org/10.1124/molpharm.120.000054
    2. Open Access
      Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast Cancer
      Balkees Abderrahman, Philipp Y. Maximov, Ramona F. Curpan, Jay S. Hanspal, Ping Fan, Rui Xiong, Debra A. Tonetti, Gregory R.J. Thatcher and V. Craig Jordan
      Molecular Pharmacology October 2020, 98 (4) 364-381; DOI: https://doi.org/10.1124/molpharm.120.000054
  4. McMahon, Lance R.

    1. You have access
      Nicotinic Acetylcholine Receptor Accessory Subunits Determine the Activity Profile of Epibatidine Derivatives
      Lu Wenchi Corrie, Clare Stokes, Jenny L. Wilkerson, F. Ivy Carroll, Lance R. McMahon and Roger L. Papke
      Molecular Pharmacology October 2020, 98 (4) 328-342; DOI: https://doi.org/10.1124/molpharm.120.000037
    2. You have access
      Nicotinic Acetylcholine Receptor Accessory Subunits Determine the Activity Profile of Epibatidine Derivatives
      Lu Wenchi Corrie, Clare Stokes, Jenny L. Wilkerson, F. Ivy Carroll, Lance R. McMahon and Roger L. Papke
      Molecular Pharmacology October 2020, 98 (4) 335-349; DOI: https://doi.org/10.1124/molpharm.120.000037
  5. Morris, J.S.

    1. You have access
      Spinal Opioid Tolerance Depends upon Platelet-Derived Growth Factor Receptor-β Signaling, Not μ-Opioid Receptor Internalization
      S. Puig, K.E. Barker, S.R. Szott, P.T. Kann, J.S. Morris and H.B. Gutstein
      Molecular Pharmacology October 2020, 98 (4) 487-496; DOI: https://doi.org/10.1124/mol.120.119552

O

  1. O’Keefe, Stephen J.

    1. You have access
      Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize Drugs
      Zdenek Dvorak, Max Klapholz, Thomas P. Burris, Benjamin P. Willing, Antimo Gioiello, Roberto Pellicciari, Francesco Galli, John March, Stephen J. O’Keefe, R. Balfour Sartor, Chang H. Kim, Maayan Levy and Sridhar Mani
      Molecular Pharmacology October 2020, 98 (4) 328-334; DOI: https://doi.org/10.1124/molpharm.120.000035
    2. You have access
      Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize Drugs
      Zdenek Dvorak, Max Klapholz, Thomas P. Burris, Benjamin P. Willing, Antimo Gioiello, Roberto Pellicciari, Francesco Galli, John March, Stephen J. O’Keefe, R. Balfour Sartor, Chang H. Kim, Maayan Levy and Sridhar Mani
      Molecular Pharmacology October 2020, 98 (4) 343-349; DOI: https://doi.org/10.1124/molpharm.120.000035
  2. Olds, J.L.

    1. You have access
      Response to Comments on “Does COVID19 Infect the Brain? If So, Smokers Might Be at a Higher Risk”
      N. Kabbani and J.L. Olds
      Molecular Pharmacology October 2020, 98 (4) 384-385; DOI: https://doi.org/10.1124/molpharm.120.000120

P

  1. Pan, Ying-Xian

    1. You have access
      A Truncated Six Transmembrane Splice Variant MOR-1G Enhances Expression of the Full-Length Seven Transmembrane μ-Opioid Receptor through Heterodimerization
      Tiffany Zhang, Jin Xu and Ying-Xian Pan
      Molecular Pharmacology October 2020, 98 (4) 518-527; DOI: https://doi.org/10.1124/mol.120.119453
  2. Papke, Roger L.

    1. You have access
      Differing Activity Profiles of the Stereoisomers of 2,3,5,6TMP-TQS, a Putative Silent Allosteric Modulator of α7 nAChR
      Roger L. Papke, Sumanta Garai, Clare Stokes, Nicole A. Horenstein, Arthur D. Zimmerman, Khalil A. Abboud and Ganesh A. Thakur
      Molecular Pharmacology October 2020, 98 (4) 292-302; DOI: https://doi.org/10.1124/mol.120.119958
    2. You have access
      Nicotinic Acetylcholine Receptor Accessory Subunits Determine the Activity Profile of Epibatidine Derivatives
      Lu Wenchi Corrie, Clare Stokes, Jenny L. Wilkerson, F. Ivy Carroll, Lance R. McMahon and Roger L. Papke
      Molecular Pharmacology October 2020, 98 (4) 328-342; DOI: https://doi.org/10.1124/molpharm.120.000037
    3. You have access
      Nicotinic Acetylcholine Receptor Accessory Subunits Determine the Activity Profile of Epibatidine Derivatives
      Lu Wenchi Corrie, Clare Stokes, Jenny L. Wilkerson, F. Ivy Carroll, Lance R. McMahon and Roger L. Papke
      Molecular Pharmacology October 2020, 98 (4) 335-349; DOI: https://doi.org/10.1124/molpharm.120.000037
  3. Parker, Kyle E.

    1. You have access
      Pain, Motivation, Migraine, and the Microbiome: New Frontiers for Opioid Systems and Disease
      Kyle E. Parker, Elizabeth Sugiarto, Anna M.W. Taylor, Amynah A. Pradhan and Ream Al-Hasani
      Molecular Pharmacology October 2020, 98 (4) 433-444; DOI: https://doi.org/10.1124/mol.120.119438
  4. Patel, S.D.

    1. You have access
      Neprilysin Controls the Synaptic Activity of Neuropeptides in the Intercalated Cells of the Amygdala
      G.C. Gregoriou, S.D. Patel, B.L. Winters and E.E. Bagley
      Molecular Pharmacology October 2020, 98 (4) 454-461; DOI: https://doi.org/10.1124/mol.119.119370
  5. Pellicciari, Roberto

    1. You have access
      Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize Drugs
      Zdenek Dvorak, Max Klapholz, Thomas P. Burris, Benjamin P. Willing, Antimo Gioiello, Roberto Pellicciari, Francesco Galli, John March, Stephen J. O’Keefe, R. Balfour Sartor, Chang H. Kim, Maayan Levy and Sridhar Mani
      Molecular Pharmacology October 2020, 98 (4) 328-334; DOI: https://doi.org/10.1124/molpharm.120.000035
    2. You have access
      Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize Drugs
      Zdenek Dvorak, Max Klapholz, Thomas P. Burris, Benjamin P. Willing, Antimo Gioiello, Roberto Pellicciari, Francesco Galli, John March, Stephen J. O’Keefe, R. Balfour Sartor, Chang H. Kim, Maayan Levy and Sridhar Mani
      Molecular Pharmacology October 2020, 98 (4) 343-349; DOI: https://doi.org/10.1124/molpharm.120.000035
  6. Pessah, Isaac N.

    1. You have access
      Dietary Caffeine Synergizes Adverse Peripheral and Central Responses to Anesthesia in Malignant Hyperthermia Susceptible Mice
      Monica Aleman, Rui Zhang, Wei Feng, Lihong Qi, Jose R. Lopez, Chelsea Crowe, Yao Dong, Genady Cherednichenko and Isaac N. Pessah
      Molecular Pharmacology October 2020, 98 (4) 351-363; DOI: https://doi.org/10.1124/mol.120.119412
  7. Pierce, Spencer R.

    1. You have access
      Analysis of Modulation of the ρ1 GABAA Receptor by Combinations of Inhibitory and Potentiating Neurosteroids Reveals Shared and Distinct Binding Sites
      Allison L. Germann, David E. Reichert, Ariel B. Burbridge, Spencer R. Pierce, Alex S. Evers, Joe Henry Steinbach and Gustav Akk
      Molecular Pharmacology October 2020, 98 (4) 280-291; DOI: https://doi.org/10.1124/mol.120.119842
    2. You have access
      Enhancement of Muscimol Binding and Gating by Allosteric Modulators of the GABAA Receptor: Relating Occupancy to State Functions
      Gustav Akk, Allison L. Germann, Yusuke Sugasawa, Spencer R. Pierce, Alex S. Evers and Joe Henry Steinbach
      Molecular Pharmacology October 2020, 98 (4) 303-313; DOI: https://doi.org/10.1124/molpharm.120.000066
  8. Pradhan, Amynah A.

    1. You have access
      Pain, Motivation, Migraine, and the Microbiome: New Frontiers for Opioid Systems and Disease
      Kyle E. Parker, Elizabeth Sugiarto, Anna M.W. Taylor, Amynah A. Pradhan and Ream Al-Hasani
      Molecular Pharmacology October 2020, 98 (4) 433-444; DOI: https://doi.org/10.1124/mol.120.119438
  9. Provasi, Davide

    1. Open Access
      Atomic-Level Characterization of the Methadone-Stabilized Active Conformation of µ-Opioid Receptor
      Abhijeet Kapoor, Davide Provasi and Marta Filizola
      Molecular Pharmacology October 2020, 98 (4) 475-486; DOI: https://doi.org/10.1124/mol.119.119339
  10. Puig, S.

    1. You have access
      Spinal Opioid Tolerance Depends upon Platelet-Derived Growth Factor Receptor-β Signaling, Not μ-Opioid Receptor Internalization
      S. Puig, K.E. Barker, S.R. Szott, P.T. Kann, J.S. Morris and H.B. Gutstein
      Molecular Pharmacology October 2020, 98 (4) 487-496; DOI: https://doi.org/10.1124/mol.120.119552
  11. Puthenveedu, Manojkumar A.

    1. You have access
      Editorial: 50 Years of Opioid Research and the International Narcotics Research Conference
      Manojkumar A. Puthenveedu
      Molecular Pharmacology October 2020, 98 (4) 386-388; DOI: https://doi.org/10.1124/molpharm.120.000132

Q

  1. Qi, Lihong

    1. You have access
      Dietary Caffeine Synergizes Adverse Peripheral and Central Responses to Anesthesia in Malignant Hyperthermia Susceptible Mice
      Monica Aleman, Rui Zhang, Wei Feng, Lihong Qi, Jose R. Lopez, Chelsea Crowe, Yao Dong, Genady Cherednichenko and Isaac N. Pessah
      Molecular Pharmacology October 2020, 98 (4) 351-363; DOI: https://doi.org/10.1124/mol.120.119412

R

  1. Reichert, David E.

    1. You have access
      Analysis of Modulation of the ρ1 GABAA Receptor by Combinations of Inhibitory and Potentiating Neurosteroids Reveals Shared and Distinct Binding Sites
      Allison L. Germann, David E. Reichert, Ariel B. Burbridge, Spencer R. Pierce, Alex S. Evers, Joe Henry Steinbach and Gustav Akk
      Molecular Pharmacology October 2020, 98 (4) 280-291; DOI: https://doi.org/10.1124/mol.120.119842

S

  1. Sartor, R. Balfour

    1. You have access
      Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize Drugs
      Zdenek Dvorak, Max Klapholz, Thomas P. Burris, Benjamin P. Willing, Antimo Gioiello, Roberto Pellicciari, Francesco Galli, John March, Stephen J. O’Keefe, R. Balfour Sartor, Chang H. Kim, Maayan Levy and Sridhar Mani
      Molecular Pharmacology October 2020, 98 (4) 328-334; DOI: https://doi.org/10.1124/molpharm.120.000035
    2. You have access
      Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize Drugs
      Zdenek Dvorak, Max Klapholz, Thomas P. Burris, Benjamin P. Willing, Antimo Gioiello, Roberto Pellicciari, Francesco Galli, John March, Stephen J. O’Keefe, R. Balfour Sartor, Chang H. Kim, Maayan Levy and Sridhar Mani
      Molecular Pharmacology October 2020, 98 (4) 343-349; DOI: https://doi.org/10.1124/molpharm.120.000035
  2. Speth, Robert C.

    1. You have access
      Commentary on: “Does COVID19 Infect the Brain? If So, Smokers Might Be at a Higher Risk”
      Robert C. Speth
      Molecular Pharmacology October 2020, 98 (4) 382-383; DOI: https://doi.org/10.1124/molpharm.120.000049
  3. Sreenivasan, Varun

    1. You have access
      Intrinsic Efficacy of Opioid Ligands and Its Importance for Apparent Bias, Operational Analysis, and Therapeutic Window
      Alexander Gillis, Varun Sreenivasan and Macdonald J. Christie
      Molecular Pharmacology October 2020, 98 (4) 410-424; DOI: https://doi.org/10.1124/mol.119.119214
  4. Steinbach, Joe Henry

    1. You have access
      Analysis of Modulation of the ρ1 GABAA Receptor by Combinations of Inhibitory and Potentiating Neurosteroids Reveals Shared and Distinct Binding Sites
      Allison L. Germann, David E. Reichert, Ariel B. Burbridge, Spencer R. Pierce, Alex S. Evers, Joe Henry Steinbach and Gustav Akk
      Molecular Pharmacology October 2020, 98 (4) 280-291; DOI: https://doi.org/10.1124/mol.120.119842
    2. You have access
      Enhancement of Muscimol Binding and Gating by Allosteric Modulators of the GABAA Receptor: Relating Occupancy to State Functions
      Gustav Akk, Allison L. Germann, Yusuke Sugasawa, Spencer R. Pierce, Alex S. Evers and Joe Henry Steinbach
      Molecular Pharmacology October 2020, 98 (4) 303-313; DOI: https://doi.org/10.1124/molpharm.120.000066
  5. Stokes, Clare

    1. You have access
      Differing Activity Profiles of the Stereoisomers of 2,3,5,6TMP-TQS, a Putative Silent Allosteric Modulator of α7 nAChR
      Roger L. Papke, Sumanta Garai, Clare Stokes, Nicole A. Horenstein, Arthur D. Zimmerman, Khalil A. Abboud and Ganesh A. Thakur
      Molecular Pharmacology October 2020, 98 (4) 292-302; DOI: https://doi.org/10.1124/mol.120.119958
    2. You have access
      Nicotinic Acetylcholine Receptor Accessory Subunits Determine the Activity Profile of Epibatidine Derivatives
      Lu Wenchi Corrie, Clare Stokes, Jenny L. Wilkerson, F. Ivy Carroll, Lance R. McMahon and Roger L. Papke
      Molecular Pharmacology October 2020, 98 (4) 328-342; DOI: https://doi.org/10.1124/molpharm.120.000037
    3. You have access
      Nicotinic Acetylcholine Receptor Accessory Subunits Determine the Activity Profile of Epibatidine Derivatives
      Lu Wenchi Corrie, Clare Stokes, Jenny L. Wilkerson, F. Ivy Carroll, Lance R. McMahon and Roger L. Papke
      Molecular Pharmacology October 2020, 98 (4) 335-349; DOI: https://doi.org/10.1124/molpharm.120.000037
  6. Sugasawa, Yusuke

    1. You have access
      Enhancement of Muscimol Binding and Gating by Allosteric Modulators of the GABAA Receptor: Relating Occupancy to State Functions
      Gustav Akk, Allison L. Germann, Yusuke Sugasawa, Spencer R. Pierce, Alex S. Evers and Joe Henry Steinbach
      Molecular Pharmacology October 2020, 98 (4) 303-313; DOI: https://doi.org/10.1124/molpharm.120.000066
  7. Sugiarto, Elizabeth

    1. You have access
      Pain, Motivation, Migraine, and the Microbiome: New Frontiers for Opioid Systems and Disease
      Kyle E. Parker, Elizabeth Sugiarto, Anna M.W. Taylor, Amynah A. Pradhan and Ream Al-Hasani
      Molecular Pharmacology October 2020, 98 (4) 433-444; DOI: https://doi.org/10.1124/mol.120.119438
  8. Szott, S.R.

    1. You have access
      Spinal Opioid Tolerance Depends upon Platelet-Derived Growth Factor Receptor-β Signaling, Not μ-Opioid Receptor Internalization
      S. Puig, K.E. Barker, S.R. Szott, P.T. Kann, J.S. Morris and H.B. Gutstein
      Molecular Pharmacology October 2020, 98 (4) 487-496; DOI: https://doi.org/10.1124/mol.120.119552

T

  1. Taylor, Anna M.W.

    1. You have access
      Pain, Motivation, Migraine, and the Microbiome: New Frontiers for Opioid Systems and Disease
      Kyle E. Parker, Elizabeth Sugiarto, Anna M.W. Taylor, Amynah A. Pradhan and Ream Al-Hasani
      Molecular Pharmacology October 2020, 98 (4) 433-444; DOI: https://doi.org/10.1124/mol.120.119438
  2. Thakur, Ganesh A.

    1. You have access
      Differing Activity Profiles of the Stereoisomers of 2,3,5,6TMP-TQS, a Putative Silent Allosteric Modulator of α7 nAChR
      Roger L. Papke, Sumanta Garai, Clare Stokes, Nicole A. Horenstein, Arthur D. Zimmerman, Khalil A. Abboud and Ganesh A. Thakur
      Molecular Pharmacology October 2020, 98 (4) 292-302; DOI: https://doi.org/10.1124/mol.120.119958
  3. Thatcher, Gregory R.J.

    1. Open Access
      Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast Cancer
      Balkees Abderrahman, Philipp Y. Maximov, Ramona F. Curpan, Jay S. Hanspal, Ping Fan, Rui Xiong, Debra A. Tonetti, Gregory R.J. Thatcher and V. Craig Jordan
      Molecular Pharmacology October 2020, 98 (4) 363-380; DOI: https://doi.org/10.1124/molpharm.120.000054
    2. Open Access
      Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast Cancer
      Balkees Abderrahman, Philipp Y. Maximov, Ramona F. Curpan, Jay S. Hanspal, Ping Fan, Rui Xiong, Debra A. Tonetti, Gregory R.J. Thatcher and V. Craig Jordan
      Molecular Pharmacology October 2020, 98 (4) 364-381; DOI: https://doi.org/10.1124/molpharm.120.000054
  4. Tonetti, Debra A.

    1. Open Access
      Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast Cancer
      Balkees Abderrahman, Philipp Y. Maximov, Ramona F. Curpan, Jay S. Hanspal, Ping Fan, Rui Xiong, Debra A. Tonetti, Gregory R.J. Thatcher and V. Craig Jordan
      Molecular Pharmacology October 2020, 98 (4) 363-380; DOI: https://doi.org/10.1124/molpharm.120.000054
    2. Open Access
      Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast Cancer
      Balkees Abderrahman, Philipp Y. Maximov, Ramona F. Curpan, Jay S. Hanspal, Ping Fan, Rui Xiong, Debra A. Tonetti, Gregory R.J. Thatcher and V. Craig Jordan
      Molecular Pharmacology October 2020, 98 (4) 364-381; DOI: https://doi.org/10.1124/molpharm.120.000054
  5. Tschirhart, Jared N.

    1. You have access
      Fentanyl-Induced Block of hERG Channels Is Exacerbated by Hypoxia, Hypokalemia, Alkalosis, and the Presence of hERG1b
      Jared N. Tschirhart and Shetuan Zhang
      Molecular Pharmacology October 2020, 98 (4) 508-517; DOI: https://doi.org/10.1124/mol.119.119271

V

  1. Valentino, Rita J.

    1. You have access
      Opioid Research: Past and Future
      Rita J. Valentino and Nora D. Volkow
      Molecular Pharmacology October 2020, 98 (4) 389-391; DOI: https://doi.org/10.1124/molpharm.120.000093
  2. Veasey, S.C.

    1. Open Access
      Bidirectional Relationship between Opioids and Disrupted Sleep: Putative Mechanisms
      D. Eacret, S.C. Veasey and J.A. Blendy
      Molecular Pharmacology October 2020, 98 (4) 445-453; DOI: https://doi.org/10.1124/mol.119.119107
  3. Volkow, Nora D.

    1. You have access
      Opioid Research: Past and Future
      Rita J. Valentino and Nora D. Volkow
      Molecular Pharmacology October 2020, 98 (4) 389-391; DOI: https://doi.org/10.1124/molpharm.120.000093
  4. von Zastrow, Mark

    1. You have access
      Opioid Pharmacology under the Microscope
      Damien Jullié, Arisbel B. Gondin, Mark von Zastrow and Meritxell Canals
      Molecular Pharmacology October 2020, 98 (4) 425-432; DOI: https://doi.org/10.1124/mol.119.119321

W

  1. Wilkerson, Jenny L.

    1. You have access
      Nicotinic Acetylcholine Receptor Accessory Subunits Determine the Activity Profile of Epibatidine Derivatives
      Lu Wenchi Corrie, Clare Stokes, Jenny L. Wilkerson, F. Ivy Carroll, Lance R. McMahon and Roger L. Papke
      Molecular Pharmacology October 2020, 98 (4) 328-342; DOI: https://doi.org/10.1124/molpharm.120.000037
    2. You have access
      Nicotinic Acetylcholine Receptor Accessory Subunits Determine the Activity Profile of Epibatidine Derivatives
      Lu Wenchi Corrie, Clare Stokes, Jenny L. Wilkerson, F. Ivy Carroll, Lance R. McMahon and Roger L. Papke
      Molecular Pharmacology October 2020, 98 (4) 335-349; DOI: https://doi.org/10.1124/molpharm.120.000037
  2. Williams, John T.

    1. You have access
      Chronic Treatment with Morphine Disrupts Acute Kinase-Dependent Desensitization of GPCRs
      Emily R. Leff, Seksiri Arttamangkul and John T. Williams
      Molecular Pharmacology October 2020, 98 (4) 497-507; DOI: https://doi.org/10.1124/mol.119.119362
    2. Open Access
      Recent Progress in Opioid Research from an Electrophysiological Perspective
      William T. Birdsong and John T. Williams
      Molecular Pharmacology October 2020, 98 (4) 401-409; DOI: https://doi.org/10.1124/mol.119.119040
  3. Willing, Benjamin P.

    1. You have access
      Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize Drugs
      Zdenek Dvorak, Max Klapholz, Thomas P. Burris, Benjamin P. Willing, Antimo Gioiello, Roberto Pellicciari, Francesco Galli, John March, Stephen J. O’Keefe, R. Balfour Sartor, Chang H. Kim, Maayan Levy and Sridhar Mani
      Molecular Pharmacology October 2020, 98 (4) 328-334; DOI: https://doi.org/10.1124/molpharm.120.000035
    2. You have access
      Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize Drugs
      Zdenek Dvorak, Max Klapholz, Thomas P. Burris, Benjamin P. Willing, Antimo Gioiello, Roberto Pellicciari, Francesco Galli, John March, Stephen J. O’Keefe, R. Balfour Sartor, Chang H. Kim, Maayan Levy and Sridhar Mani
      Molecular Pharmacology October 2020, 98 (4) 343-349; DOI: https://doi.org/10.1124/molpharm.120.000035
  4. Winters, B.L.

    1. You have access
      Neprilysin Controls the Synaptic Activity of Neuropeptides in the Intercalated Cells of the Amygdala
      G.C. Gregoriou, S.D. Patel, B.L. Winters and E.E. Bagley
      Molecular Pharmacology October 2020, 98 (4) 454-461; DOI: https://doi.org/10.1124/mol.119.119370

X

  1. Xiong, Rui

    1. Open Access
      Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast Cancer
      Balkees Abderrahman, Philipp Y. Maximov, Ramona F. Curpan, Jay S. Hanspal, Ping Fan, Rui Xiong, Debra A. Tonetti, Gregory R.J. Thatcher and V. Craig Jordan
      Molecular Pharmacology October 2020, 98 (4) 363-380; DOI: https://doi.org/10.1124/molpharm.120.000054
    2. Open Access
      Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast Cancer
      Balkees Abderrahman, Philipp Y. Maximov, Ramona F. Curpan, Jay S. Hanspal, Ping Fan, Rui Xiong, Debra A. Tonetti, Gregory R.J. Thatcher and V. Craig Jordan
      Molecular Pharmacology October 2020, 98 (4) 364-381; DOI: https://doi.org/10.1124/molpharm.120.000054
  2. Xu, Jin

    1. You have access
      A Truncated Six Transmembrane Splice Variant MOR-1G Enhances Expression of the Full-Length Seven Transmembrane μ-Opioid Receptor through Heterodimerization
      Tiffany Zhang, Jin Xu and Ying-Xian Pan
      Molecular Pharmacology October 2020, 98 (4) 518-527; DOI: https://doi.org/10.1124/mol.120.119453

Z

  1. Zhang, Rui

    1. You have access
      Dietary Caffeine Synergizes Adverse Peripheral and Central Responses to Anesthesia in Malignant Hyperthermia Susceptible Mice
      Monica Aleman, Rui Zhang, Wei Feng, Lihong Qi, Jose R. Lopez, Chelsea Crowe, Yao Dong, Genady Cherednichenko and Isaac N. Pessah
      Molecular Pharmacology October 2020, 98 (4) 351-363; DOI: https://doi.org/10.1124/mol.120.119412
  2. Zhang, Shetuan

    1. You have access
      Fentanyl-Induced Block of hERG Channels Is Exacerbated by Hypoxia, Hypokalemia, Alkalosis, and the Presence of hERG1b
      Jared N. Tschirhart and Shetuan Zhang
      Molecular Pharmacology October 2020, 98 (4) 508-517; DOI: https://doi.org/10.1124/mol.119.119271
  3. Zhang, Tiffany

    1. You have access
      A Truncated Six Transmembrane Splice Variant MOR-1G Enhances Expression of the Full-Length Seven Transmembrane μ-Opioid Receptor through Heterodimerization
      Tiffany Zhang, Jin Xu and Ying-Xian Pan
      Molecular Pharmacology October 2020, 98 (4) 518-527; DOI: https://doi.org/10.1124/mol.120.119453
  4. Zimmerman, Arthur D.

    1. You have access
      Differing Activity Profiles of the Stereoisomers of 2,3,5,6TMP-TQS, a Putative Silent Allosteric Modulator of α7 nAChR
      Roger L. Papke, Sumanta Garai, Clare Stokes, Nicole A. Horenstein, Arthur D. Zimmerman, Khalil A. Abboud and Ganesh A. Thakur
      Molecular Pharmacology October 2020, 98 (4) 292-302; DOI: https://doi.org/10.1124/mol.120.119958
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 98 (4)
Molecular Pharmacology
Vol. 98, Issue 4
1 Oct 2020
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics